Nancy Ryan Gray

LGND

Nancy Ryan Gray serves as Director at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$2.78M

Net Position

Net Seller

$2.78M

Companies Traded

LGND, LGNDZ

Active Period

May 2024 – Nov 2025

3 total trades

Most Recent

Sell LGND

Nov 12, 2025 · $1.35M

Nancy Ryan Gray's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

2 · $1.43M

Total Shares Bought

Total Shares Sold

7,505

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 12, 2025	Sell	6,571	$205.45	$1.35M	8,094
May 17, 2024	Sell	934	$83.20	$77.7K	5,633

Nancy Ryan Gray's Insider Trading at LIGAND PHARMS INC CVR (LGNDZ)

Buys

0 · $0.00

Sells

1 · $1.35M

Total Shares Bought

Total Shares Sold

6,571

LGNDZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 7, 2025	Sell	6,571	$205.45	$1.35M	0

Related Insiders

Andrew Reardon

officer: CLO & Secretary

LGNDSell · Apr 2, 2026

KOZARICH JOHN W

Director

LGNDSell · Apr 2, 2026

LAMATTINA JOHN L

Director

LGNDSell · Mar 31, 2026

Stephen L Sabba

director

LGNDSell · Mar 25, 2026

Octavio Espinoza

officer: Chief Financial Officer

LGNDSell · Mar 13, 2026

KOZARICH JOHN W

Director

LGNDZSell · Feb 2, 2026

Octavio Espinoza

Chief Financial Officer

LGNDZSell · Dec 12, 2025

LAMATTINA JOHN L

Director

LGNDZSell · Nov 7, 2025

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity